No increased in utero and peripartum HIV acquisition risk in HIV-exposed preterm infants

Southern African Journal of HIV Medicine

 
 
Field Value
 
Title No increased in utero and peripartum HIV acquisition risk in HIV-exposed preterm infants
 
Creator Ajibola, Gbolahan Mdluli, Charlotte Bennett, Kara Sakoi, Maureen Batlang, Oganne Makhema, Joseph Lockman, Shahin Shapiro, Roger Myer, Landon Powis, Kathleen
 
Subject — HIV acquisition risk; preterm neonates; vertical transmission; women living with HIV; antiretroviral treatment
Description Background: Limited data exist on the differential risk of HIV acquisition between infants born preterm versus those born at term to women living with HIV (WLHIV). With a reported increase in preterm delivery among pregnant WLHIV, understanding the risk of vertical transmission of HIV in preterm infants can inform strategies to optimise the timing of diagnostic testing, antiretroviral prophylaxis, and infant feeding.Objectives: To describe the prevalence and timing of HIV acquisition, in utero versus perinatal, among infants with perinatal HIV exposure born prior to 37 weeks completed gestation age compared to those born at term in the Botswana-based Mpepu study and explore predictors of infant HIV acquisition.Method: Using data extracted from the Mpepu study, we describe the prevalence, timing and risk factors for HIV acquisition in infants born preterm versus those born at term. Fisher exact testing was used to test for differences in prevalence and timing of HIV and a multivariable logistic regression model was used to assess risk factors for infant HIV acquisition.Results: 2866 infants born to WLHIV were included in this secondary analysis. 532 (19%) were born preterm. There was no observed difference in the prevalence of HIV acquisition among infants born preterm versus at term overall (0.8% vs 0.6%, P = 0.54), at birth (0.2% vs 0.3%, P = 1.00) or between 14 and 34 days post-delivery (0.6% vs 0.3%, P = 0.41). The absence of maternal antiretroviral use during pregnancy significantly predicted infant HIV acquisition, with the risk of HIV acquisition reduced by 96% among infants whose mothers were taking antiretroviral treatment (ART) during pregnancy (adjusted odds ratio: 0.003, confidence interval: 0.01–0.02, P 0.001).Conclusion: There was no observed increase of in utero and peripartum HIV acquisition among infants born preterm following foetal exposure to HIV compared to those born at term.
 
Publisher AOSIS
 
Contributor Funding provided by EDCTP
Date 2023-10-19
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — Secondary Data Analysis
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/sajhivmed.v24i1.1509
 
Source Southern African Journal of HIV Medicine; Vol 24, No 1 (2023); 6 pages 2078-6751 1608-9693
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajhivmed.org.za/index.php/hivmed/article/view/1509/3147 https://sajhivmed.org.za/index.php/hivmed/article/view/1509/3148 https://sajhivmed.org.za/index.php/hivmed/article/view/1509/3149 https://sajhivmed.org.za/index.php/hivmed/article/view/1509/3150
 
Coverage — — —
Rights Copyright (c) 2023 Gbolahan Ajibola, Charlotte Mdluli, Kara Bennett, Maureen Sakoi, Oganne Batlang, Joseph Makhema, Shahin Lockman, Roger Shapiro, Landon Myer, Kathleen Powis https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT